Coronary Artery Disease Clinical Trials in Jacksonville, Florida

11 studies are recruiting for coronary artery disease in Jacksonville, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Product Surveillance Registry

   The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is intended to benefit and support interests of patients, hospitals, clinicians, regulatory bodies, payers, and industry by str…

   Stage

   Not phased

   Ages

   Any age

   Site

   Research site, Jacksonville, Florida

   Locations

   401 in total

   Run by

   Medtronic

   See if you can join NCT01524276 on ClinicalTrials.gov

2. Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

   Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease, but there is limited information on the techniques utilized and the procedural outcomes. The goal of this multicenter, investigator initiate…

   Stage

   Not phased

   Ages

   Any age

   Site

   Memorial Hospital, Jacksonville, Florida

   Locations

   48 in total

   Run by

   Minneapolis Heart Institute Foundation

   See if you can join NCT02061436 on ClinicalTrials.gov

3. SELUTION 4 De Novo Small Vessel IDE Trial

   Prospective, randomized controlled, single-blind, multicenter, clinical trial to demonstrate the safety and efficacy of the SELUTION SLR 014 PTCA DEB for treatment of de novo lesions in small coronary vessels, defined as reference vessel diameter (RVD) of 2.00 mm to 2.75 mm, in support of a pre-mar…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Florida, Jacksonville, Jacksonville, Florida

   Locations

   70 in total

   Run by

   M.A. Med Alliance S.A.

   See if you can join NCT05946629 on ClinicalTrials.gov

4. Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

   Dual antiplatelet therapy (DAPT) with low-dose aspirin and a P2Y12 inhibitor is the current standard of care in patients with coronary artery disease experiencing an acute event or undergoing percutaneous coronary intervention. However, the ischemic benefits are counterbalanced by a significant inc…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   University of Florida, Jacksonville, Florida

   Run by

   University of Florida

   See if you can join NCT06821191 on ClinicalTrials.gov

5. Tailoring Bleeding Reduction Approaches in Patients Undergoing PCI

   Two strategies have both proven to be effective in reducing bleeding complications while preserving efficacy compared with maintaining long-term DAPT with aspirin and a potent P2Y12 inhibitor: a) DAPT de-escalation (i.e., switching from prasugrel or ticagrelor to clopidogrel while maintaining aspir…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   University of Florida, Jacksonville, Florida

   Run by

   University of Florida

   See if you can join NCT05681702 on ClinicalTrials.gov

6. Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

   The proposed study aims to assess the antiplatelet effects of more potent oral P2Y12 inhibition with low-dose ticagrelor (60 mg bid) compared with standard of care clopidogrel in patients with a high ABCD-GENE score (≥10). We hypothesize that ticagrelor is associated with better pharmacodynamic eff…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   University of Florida Jacksonville, Jacksonville, Florida

   Run by

   University of Florida

   See if you can join NCT06228456 on ClinicalTrials.gov

7. Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors

   Ticagrelor currently represents the most tested and commonly used P2Y12 inhibitor monotherapy following percutaneous coronary intervention. The purpose of this study is to conduct a head-to-head comparison on the pharmacodynamic efficacy of ticagrelor-based and prasugrel-based single antiplatelet t…

   Stage

   Phase 4

   Ages

   18 to 75

   Site

   University of Florida Jacksonville, Jacksonville, Florida

   Run by

   University of Florida

   See if you can join NCT06691191 on ClinicalTrials.gov

8. A Precision Medicine Approach to Identify Patients Undergoing Elective PCI at Risk of Peri-PCI Myocardial Infarction

   Despite the relative safety of PCI with new generation stents, peri-PCI thrombotic complications, including myocardial infarction and myocardial injury, are common in elective PCI, occurring in up to 30% of patients. Importantly, these events are associated with poor prognosis. The risk of peri-PCI…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Florida Jacksonville, Jacksonville, Florida

   Run by

   University of Florida

   See if you can join NCT05332262 on ClinicalTrials.gov

9. MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

   This is a multicenter, randomized, single-blind pivotal study to evaluate the safety and efficacy of the MagicTouchTM Drug coated balloon in treatment of small vessels in patients with coronary artery disease. The objective is to establish the safety and efficacy of the Magic TouchTM Drug coated ba…

   Stage

   Not phased

   Ages

   18 to 80

   Site

   University of Florida Health Sciences Center-Jacksonville, Jacksonville, Florida

   Locations

   24 in total

   Run by

   Concept Medical Inc.

   See if you can join NCT06271590 on ClinicalTrials.gov

10. Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

    Patients undergoing transcatheter aortic valve replacement (TAVR) often have concomitant coronary artery disease (CAD) which may adversely affect prognosis. There is uncertainty about the benefits and the optimal timing of revascularization for such patients. There is currently clinical equipoise r…

    Stage

    Not phased

    Ages

    Any age

    Site

    Baptist Health Jacksonville, Jacksonville, Florida

    Locations

    72 in total

    Run by

    University of British Columbia

    See if you can join NCT04634240 on ClinicalTrials.gov

11. PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm

    This purpose of this trial is to demonstrate 30 day safety and effectiveness outcomes of the KARDION CORY P4 System in subjects who require hemodynamic support during a high-risk PCI procedure.

    Stage

    Not phased

    Ages

    18 to 90

    Site

    Ascension St. Vincent's, Jacksonville, Florida

    Locations

    18 in total

    Run by

    Kardion Inc

    See if you can join NCT06445608 on ClinicalTrials.gov